---
id: "seo-jung-jin"
name: "Seo Jung-jin"
birth: "1957-04-15"
death: "Unknown"
nationality: "South Korean"
occupation: ["Entrepreneur", "Industrialist"]
image: ""
socialLinks:
  wikipedia: "https://en.wikipedia.org/wiki/Seo_Jung-jin"
lastUpdated: "2026-02-21"
---

## Summary

Seo Jung-jin co-founded Celltrion and built it into a global biosimilar pharmaceutical powerhouse. He invested heavily in biopharmaceutical manufacturing when few Korean companies were pursuing biosimilars. Celltrion's success in gaining European approval for biosimilar infliximab opened the global biosimilar market. He is one of South Korea's wealthiest individuals through his Celltrion stake.

## Career Timeline

| Year | Event |
|------|-------|
| 1957 | Born in South Korea |
| 2002 | Co-founded Celltrion |
| 2013 | Celltrion's Remsima approved in EU |
| 2017 | Celltrion Healthcare expanded global distribution |
| 2023 | Merged Celltrion and Celltrion Healthcare |
| 2024 | Celltrion expanded into novel drug development |

## References

[^1]: Wikipedia, "Seo Jung-jin" - https://en.wikipedia.org/wiki/Seo_Jung-jin
